Human Embryonic Stem Cells Market Report

China Human Embryonic Stem Cells Industry Market Research Report 2023-2029

  • POSTDATE：Aug 27, 2023
  • PAGES：195
  • REPORT CODE：GMM1761921
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Human Embryonic Stem Cells industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Lonza Group Ltd

    • Beike Biotechnology

    • Orthofix International NV

    • TiGenix NV

    • Anterogen Co, Ltd

    • Sumanas

    • Kite Pharma Inc

    • NuVasive Inc

    • Genlantis

    • Vericel Corporation

    • CellTherapies P/L

    • Ocata Therapeutics Inc

    • Aastrom Biosciences

    • Cesca Therapeutics Inc

    • Life Technologies Corporation

    • BioRestorative Therapies Inc

    By Type:

    • Others

    • Fetal Sources

    • Adult Sources

    By Application:

    • As gene therapy vectors

    • Autoimmune diseases

    • Hematopoietic stem cell transplantation

    • Tissue repair damage

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Human Embryonic Stem Cells Market Overview 2018-2029

    • 1.1 China Human Embryonic Stem Cells Industry Development Overview

    • 1.2 China Human Embryonic Stem Cells Industry Development History

    • 1.3 China Human Embryonic Stem Cells Industry Market Size (2018-2029)

    • 1.4 China Human Embryonic Stem Cells Market Analysis by Type from Production Side

      • 1.4.1 China Human Embryonic Stem Cells Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Human Embryonic Stem Cells Production Volume, Production Value and Growth Rate of Fetal Sources (2018-2029)

      • 1.4.3 China Human Embryonic Stem Cells Production Volume, Production Value and Growth Rate of Adult Sources (2018-2029)

    • 1.5 China Human Embryonic Stem Cells Market Analysis by Application from Consumption End

      • 1.5.1 China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of As gene therapy vectors (2018-2029)

      • 1.5.2 China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of Autoimmune diseases (2018-2029)

      • 1.5.3 China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of Hematopoietic stem cell transplantation (2018-2029)

      • 1.5.4 China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of Tissue repair damage (2018-2029)

    • 1.6 China Human Embryonic Stem Cells Market Analysis by Region

      • 1.6.1 North China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    Chapter 2 China Human Embryonic Stem Cells Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Human Embryonic Stem Cells Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Human Embryonic Stem Cells Market Status and Competition Analysis in 2023

      • 2.2.3 China Human Embryonic Stem Cells Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Human Embryonic Stem Cells Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Human Embryonic Stem Cells Industry Development

    Chapter 3 Human Embryonic Stem CellsIndustry Chain Analysis

    • 3.1 Human Embryonic Stem Cells Industry Chain

    • 3.2 Human Embryonic Stem Cells Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Human Embryonic Stem Cells Market

    • 3.3 Human Embryonic Stem Cells Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Human Embryonic Stem Cells Market

    Chapter 4 China Human Embryonic Stem Cells Market, by Type

    • 4.1 China Human Embryonic Stem Cells Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Human Embryonic Stem Cells Total Production Volume and Growth Rate from Production Side

    • 4.5 China Human Embryonic Stem Cells Production Volume and Growth Rate, by Type

      • 4.5.1 China Human Embryonic Stem Cells Production Volume and Growth Rate of Others

      • 4.5.2 China Human Embryonic Stem Cells Production Volume and Growth Rate of Fetal Sources

      • 4.5.3 China Human Embryonic Stem Cells Production Volume and Growth Rate of Adult Sources

    Chapter 5 China Human Embryonic Stem Cells Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Human Embryonic Stem Cells Total Market Size and Growth Rate from Consumption End

    • 5.5 China Human Embryonic Stem Cells Market Size and Growth Rate, by Application

      • 5.5.1 China Human Embryonic Stem Cells Market Size and Growth Rate of As gene therapy vectors

      • 5.5.2 China Human Embryonic Stem Cells Market Size and Growth Rate of Autoimmune diseases

      • 5.5.3 China Human Embryonic Stem Cells Market Size and Growth Rate of Hematopoietic stem cell transplantation

      • 5.5.4 China Human Embryonic Stem Cells Market Size and Growth Rate of Tissue repair damage

    Chapter 6 China Human Embryonic Stem Cells Market, by Region

    • 6.1 China Human Embryonic Stem Cells Production Volume and Production Value, by Region

    • 6.2 China Human Embryonic Stem Cells Sales Volume and Sales Value, by Region

    Chapter 7 North China Human Embryonic Stem Cells Market Analysis

    • 7.1 North China Human Embryonic Stem Cells Market, by Type

    • 7.2 North China Human Embryonic Stem Cells Market, by Application

    Chapter 8 Central China Human Embryonic Stem Cells Market Analysis

    • 8.1 Central China Human Embryonic Stem Cells Market, by Type

    • 8.2 Central China Human Embryonic Stem Cells Market, by Application

    Chapter 9 South China Human Embryonic Stem Cells Market Analysis

    • 9.1 South China Human Embryonic Stem Cells Market, by Type

    • 9.2 South China Human Embryonic Stem Cells Market, by Application

    Chapter 10 East China Human Embryonic Stem Cells Market Analysis

    • 10.1 East China Human Embryonic Stem Cells Market, by Type

    • 10.2 East China Human Embryonic Stem Cells Market, by Application

    Chapter 11 Northeast China Human Embryonic Stem Cells Market Analysis

    • 11.1 Northeast China Human Embryonic Stem Cells Market, by Type

    • 11.2 Northeast China Human Embryonic Stem Cells Market, by Application

    Chapter 12 Southwest China Human Embryonic Stem Cells Market Analysis

    • 12.1 Southwest China Human Embryonic Stem Cells Market, by Type

    • 12.2 Southwest China Human Embryonic Stem Cells Market, by Application

    Chapter 13 Northwest China Human Embryonic Stem Cells Market Analysis

    • 13.1 Northwest China Human Embryonic Stem Cells Market, by Type

    • 13.2 Northwest China Human Embryonic Stem Cells Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Lonza Group Ltd

        • 14.1.1 Lonza Group Ltd Company Profile

        • 14.1.2 Lonza Group Ltd Human Embryonic Stem Cells Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Beike Biotechnology

        • 14.2.1 Beike Biotechnology Company Profile

        • 14.2.2 Beike Biotechnology Human Embryonic Stem Cells Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Orthofix International NV

        • 14.3.1 Orthofix International NV Company Profile

        • 14.3.2 Orthofix International NV Human Embryonic Stem Cells Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 TiGenix NV

        • 14.4.1 TiGenix NV Company Profile

        • 14.4.2 TiGenix NV Human Embryonic Stem Cells Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Anterogen Co, Ltd

        • 14.5.1 Anterogen Co, Ltd Company Profile

        • 14.5.2 Anterogen Co, Ltd Human Embryonic Stem Cells Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sumanas

        • 14.6.1 Sumanas Company Profile

        • 14.6.2 Sumanas Human Embryonic Stem Cells Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Kite Pharma Inc

        • 14.7.1 Kite Pharma Inc Company Profile

        • 14.7.2 Kite Pharma Inc Human Embryonic Stem Cells Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 NuVasive Inc

        • 14.8.1 NuVasive Inc Company Profile

        • 14.8.2 NuVasive Inc Human Embryonic Stem Cells Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Genlantis

        • 14.9.1 Genlantis Company Profile

        • 14.9.2 Genlantis Human Embryonic Stem Cells Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Vericel Corporation

        • 14.10.1 Vericel Corporation Company Profile

        • 14.10.2 Vericel Corporation Human Embryonic Stem Cells Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 CellTherapies P/L

        • 14.11.1 CellTherapies P/L Company Profile

        • 14.11.2 CellTherapies P/L Human Embryonic Stem Cells Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Ocata Therapeutics Inc

        • 14.12.1 Ocata Therapeutics Inc Company Profile

        • 14.12.2 Ocata Therapeutics Inc Human Embryonic Stem Cells Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Aastrom Biosciences

        • 14.13.1 Aastrom Biosciences Company Profile

        • 14.13.2 Aastrom Biosciences Human Embryonic Stem Cells Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Cesca Therapeutics Inc

        • 14.14.1 Cesca Therapeutics Inc Company Profile

        • 14.14.2 Cesca Therapeutics Inc Human Embryonic Stem Cells Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Life Technologies Corporation

        • 14.15.1 Life Technologies Corporation Company Profile

        • 14.15.2 Life Technologies Corporation Human Embryonic Stem Cells Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 BioRestorative Therapies Inc

        • 14.16.1 BioRestorative Therapies Inc Company Profile

        • 14.16.2 BioRestorative Therapies Inc Human Embryonic Stem Cells Market Performance

        • 14.16.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Human Embryonic Stem Cells Industry Research Conclusions

    • 15.2 Human Embryonic Stem Cells Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Human Embryonic Stem Cells Industry Market Size (2018-2029)

    • Figure China Human Embryonic Stem Cells Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Human Embryonic Stem Cells Production Volume, Production Value and Growth Rate of Fetal Sources (2018-2029)

    • Figure China Human Embryonic Stem Cells Production Volume, Production Value and Growth Rate of Adult Sources (2018-2029)

    • Figure China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of As gene therapy vectors (2018-2029)

    • Figure China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of Autoimmune diseases (2018-2029)

    • Figure China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of Hematopoietic stem cell transplantation (2018-2029)

    • Figure China Human Embryonic Stem Cells Sales Volume, Sales Value and Growth Rate of Tissue repair damage (2018-2029)

    • Figure North China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Central China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure South China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure East China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Human Embryonic Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Human Embryonic Stem Cells Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Human Embryonic Stem Cells Market Share by Type in 2018

    • Figure China Human Embryonic Stem Cells Market Share by Type in 2023

    • Figure China Human Embryonic Stem Cells Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Human Embryonic Stem Cells Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Human Embryonic Stem Cells Production Volume and Growth Rate of Fetal Sources (2018-2023)

    • Figure China Human Embryonic Stem Cells Production Volume and Growth Rate of Adult Sources (2018-2023)

    • Figure China Human Embryonic Stem Cells Market Share by Application in 2018

    • Figure China Human Embryonic Stem Cells Market Share by Application in 2023

    • Figure China Human Embryonic Stem Cells Total Market Size and Growth Rate from Consumption End

    • Figure China Human Embryonic Stem Cells Market Size and Growth Rate of As gene therapy vectors (2018-2023)

    • Figure China Human Embryonic Stem Cells Market Size and Growth Rate of Autoimmune diseases (2018-2023)

    • Figure China Human Embryonic Stem Cells Market Size and Growth Rate of Hematopoietic stem cell transplantation (2018-2023)

    • Figure China Human Embryonic Stem Cells Market Size and Growth Rate of Tissue repair damage (2018-2023)

    • Table China Human Embryonic Stem Cells Production Volume by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Production Volume Share by Region (2018-2023)

    • Figure China Human Embryonic Stem Cells Production Volume Share by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Production Value by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Production Value Share by Region (2018-2023)

    • Figure China Human Embryonic Stem Cells Production Value Share by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Sales Volume by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Sales Volume Share by Region (2018-2023)

    • Figure China Human Embryonic Stem Cells Sales Volume Share by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Sales Value by Region (2018-2023)

    • Table China Human Embryonic Stem Cells Sales Value Share by Region (2018-2023)

    • Figure China Human Embryonic Stem Cells Sales Value Share by Region (2018-2023)

    • Table North China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table North China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure North China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table North China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table North China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure North China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Central China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table Central China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Central China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table Central China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table Central China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Central China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table South China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table South China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure South China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table South China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table South China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure South China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table East China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table East China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure East China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table East China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table East China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure East China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Northeast China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table Northeast China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Northeast China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table Northeast China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table Northeast China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Southwest China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table Southwest China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Southwest China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table Southwest China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table Southwest China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Northwest China Human Embryonic Stem Cells Production Volume by Type (2018-2023)

    • Table Northwest China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Northwest China Human Embryonic Stem Cells Production Volume Share by Type (2018-2023)

    • Table Northwest China Human Embryonic Stem Cells Sales Volume by Application (2018-2023)

    • Table Northwest China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Human Embryonic Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Lonza Group Ltd Company Profile

    • Table Lonza Group Ltd Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Beike Biotechnology Company Profile

    • Table Beike Biotechnology Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Orthofix International NV Company Profile

    • Table Orthofix International NV Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table TiGenix NV Company Profile

    • Table TiGenix NV Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Anterogen Co, Ltd Company Profile

    • Table Anterogen Co, Ltd Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Sumanas Company Profile

    • Table Sumanas Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Kite Pharma Inc Company Profile

    • Table Kite Pharma Inc Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table NuVasive Inc Company Profile

    • Table NuVasive Inc Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Genlantis Company Profile

    • Table Genlantis Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Vericel Corporation Company Profile

    • Table Vericel Corporation Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table CellTherapies P/L Company Profile

    • Table CellTherapies P/L Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Ocata Therapeutics Inc Company Profile

    • Table Ocata Therapeutics Inc Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Aastrom Biosciences Company Profile

    • Table Aastrom Biosciences Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Cesca Therapeutics Inc Company Profile

    • Table Cesca Therapeutics Inc Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Life Technologies Corporation Company Profile

    • Table Life Technologies Corporation Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)

    • Table BioRestorative Therapies Inc Company Profile

    • Table BioRestorative Therapies Inc Human Embryonic Stem Cells Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US